65,437 trials
Locally Advanced Non-Small Cell Lung Cancer
Primary: Number of Dose Limiting Toxicities in Patients Taking Atovaquone in Combination With Radical Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer. — 0; 0; 0; 2…
Corona Virus Disease
Primary: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinity (AUCinf) — 4642; 4980; 4666; 2357 day*μg/mL
Down Syndrome · Physical Inactivity
Primary: Minutes of Gameplay Per Week — 100.32 minutes/week
Atrial Fibrillation · Syncope · Cryptogenic Stroke
Primary: ICM System-related Complication-free Rate at 30 Days Post-implant — 99.9 Percentage of participants
Tobacco Use
Primary: Summary of Urine Total NNAL Amount Excreted and Absolute Change From Baseline (ng/24 Hour) by Study Group and Study Day (mITT Population) — 511.889; 581.676; 548.751…
Mental Health Wellness 1 · Sexual Orientation · Gender Identity
Primary: Patient Health Questionnaire (PHQ-9) — 14.29; 11.50 score on a scale
Gestational Diabetes
Primary: Changes in Fasting Glucose — 10.4; 1.6 mg/dL
Non-Small Cell Lung Cancer
Primary: Progression Free Survival (PFS) Assessed by Independent Review Committee (IRC) Assessment — 9.7; 7.6 Months — p=0.0054
Metastatic Colorectal Cancer
Primary: Disease Stabilisation Rate — 0 Participants
Suicide · Nurse's Role · Work Environment Adverse Effects
Primary: Columbia Suicide Severity Rating Scale (Intensity of Ideation) - Number of Participants With a Positive CSSRS Ideation — 2 Participants
Leiomyosarcoma · Liposarcoma · Soft Tissue Sarcoma Adult
Primary: The Objective Response Rate (ORR) Based on RECIST 1.1 — 6 Participants
Nasal Polyps
Primary: Mean Change From Baseline in Total Endoscopic Nasal Polyps (NP) Score at Week 52 - ITT Population Excluding Medipharma Managed Sites — -0.62; -0.19 Scores on a Scale…
Clubfoot
Primary: Recruitment of Patients for a Prospective Trial Comparing Clubfoot Brace Types — 59; 17 Participants
Amyotrophic Lateral Sclerosis
Primary: The Amounts of Change of Landmarks Position According to Posture — 1.0; 2.4; 2.9; 5.6 mm
Opioid Overdose
Primary: Number of Opioid-related Adverse Events — 4.15; 3.24 Events